- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Piramal Pharma Limited — Updates, 20-03-2026: General Updates
20-03-2026 | 08:28 pm
20-03-2026 | 08:28 pm
Piramal Pharma received an ESG Rating of '68.5' for FY24-25 from SES ESG Research. The company noted this rating was voluntarily assigned by SES ESG, not at PPLPHARMA's request.
No comments yet. Be the first to comment!